Daiichi Sankyo shows updated Phase 1 Data for U3-1402 in cancer patient

Daiichi Sankyo Company, Limited announced that updated efficacy and safety results from the ongoing phase 1/2 study...

December 6, 2018 | Thursday | News
AGC enters agreement to acquire Malgrat Pharma

AGC Inc., a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered in...

December 5, 2018 | Wednesday | News
VSee Telehealth launches in Japan

VSee, the telehealth company behind NASA International Space Station, Walgreens, MDLIVE, DaVita, Trinity, Ascension and ...

December 5, 2018 | Wednesday | News
Researchers develop platelets in lab

Researchers have developed a way to grow human platelets in the laboratory from stem cells derived from fat tissue. Thes...

November 30, 2018 | Friday | News
Sun Pharma acquires Japan's Pola Pharma

Sun Pharmaceutical, recently announced that it has entered into a definitive agreement to acquire Pola Pharma Inc. (&ldq...

November 29, 2018 | Thursday | News
AminoIndex risk screening: Catching cancer before it starts

Singapore - The fact that Japanese people have the longest lifespan in the world—and that they live healthier well...

November 29, 2018 | Thursday | News
Ono files for approval of ONO-7643 in Japan

Ono Pharmaceutical  announced today that ONO has submitted in Japan an application for manufacturing and marketing ...

November 28, 2018 | Wednesday | News
Daiichi Sankyo launches Trastuzumab Biosimilar in Japan

Daiichi Sankyo Company, Limited has launched the antitumor agent trastuzumab Biosimilar for intravenous drip infusions 6...

November 28, 2018 | Wednesday | News
Sysmex, MolecularMD commence global partnership

Sysmex Corporation, a Japanese in vitro diagnostics company, and MolecularMD Corporation, a US based molecular diagnosti...

November 28, 2018 | Wednesday | News
EC Approves Takeda’s ALUNBRIG for ALK+ Non-Small Cell Lung Cancer

Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...

November 28, 2018 | Wednesday | News
Eisai to present new research on Eribulin at SABC Symposium

Eisai Co., Ltd. has announced that the latest information on its in-house discovered and developed anticancer agent erib...

November 27, 2018 | Tuesday | News
Mitsui invests in Indian healthcare platform biz

Mitsui & Co. ("Mitsui") on November 21, 2018, acquired a stake in GOQii Inc. ("GOQii"), a business providing a preve...

November 26, 2018 | Monday | News
Japan Govt. takes lead to collaborate Japanese Healthcare with Germany

As the world's third largest economy, Japan is leading the way for aging societies. Therefore, the Government ...

November 23, 2018 | Friday | News
Eisai to present latest data on Perampanel at AES annual meeting

Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will b...

November 23, 2018 | Friday | News
Takeda receives clearance from EC for proposed acquisition of Shire

Takeda has announced that it has received clearance from the European Commission for the proposed acquisition of Shire a...

November 22, 2018 | Thursday | News
Alvotech, Fuji Pharma partner for biosimilars

Alvotech and Fuji Pharma has announced that the two companies are entering into an exclusive partnership for the commerc...

November 20, 2018 | Tuesday | News
Mundipharma to bring world's first gene therapy for knee osteoarthritis

In a multi-year agreement for up to USD 600 million, Mundipharma has acquired the exclusive rights for Invossa in Japan ...

November 19, 2018 | Monday | News
Karl Deisseroth receives Japan’s Kyoto prize in advanced technology

The Inamori Foundation has announced that it has presented its 34th annual Kyoto Prize in Advanced Technology to Dr. Kar...

November 19, 2018 | Monday | News